01022-6/asset/a38873d9-5999-4e60-a3fc-c2fd1cbeca3d/main.assets/gr2_lrg.jpg)
cagrilintide semaglutide combination cagrisema phase 3 2025 Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Cagrilintide–semaglutide (CagriSema) as an add-on
Description
Prescription treatment is only available when medically appropriate and prescribed by a licensed provider
The prescription medicine is being sold in underground markets and on e-commerce platforms for double the price.
GLP-1 (Glucagon like peptide-1 receptor agonists)
Women with uterine fibroids have a more than 80 percent higher risk of developing heart disease, according to a new study
